https://www.selleckchem.com/products/LBH-589.html
The mean dose delivered to the lungs was 11.4Gy (IC 95% 4.8-19.8), the median volumes receiving up to 20Gy (V2 and 30Gy (V3 were 13.5% (3.0-46. and 4.6% (0.7-19.8) respectively. The mean dose delivered to the heart was 13.9Gy (IC 95%0.3-31.3) with a median V40 of 3.3% (0.0-25.. One treatment-related death occurred within days after RT completion (neutropenic aplasia). After a median follow-up of 2.7 years (95% CI 1.9-4.3), the 2-year overall survival, disease free survival and loco-regional control rates were 53.6%, 42.0% and 72
Like
Comment
Share
